๐ฐ Three Phase News
Page 6 - Three Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Three Phase. Real-time updates on events, politics, business and more.
January 12, 2023
- Seven posters will include clinical data for VTAMA cream for the treatment of plaque psoriasis in adults and atopic dermatitis (AD), including data from the successful pediatric maximum usage study
December 15, 2022
/PRNewswire/ -- The global power tools market size is estimated to be USD 42.8 billion in 2022 and is projected to reach USD 65.5 billion by 2027 at a CAGR of...
December 15, 2022
CHICAGO, Dec. 15, 2022 /PRNewswire/ -- The global power tools market size is estimated to be USD 42.8 billion in 2022 and is projected to reach USD 65.5 billion by 2027 at a CAGR of 8.9% according
December 15, 2022
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of the Global Renewable Energy...
December 5, 2022
Custom Market Insights has published a new research report titledย "Lead Acid Battery Market Size, Trends and Insights By Product (SSL Lead Acid Battery,
December 1, 2022
Trilliant's technology and expertise to further enable ESB Networks as it upgrades electricity meters in homes, farms and businesses in the Republic of Ireland Enlit Europe 2022 Trilliant, a leading
November 21, 2022
Custom Market Insights has published a new research report titledย โGreen Hydrogen Market Size, Trends and Insights By Technology (Polymer Electrolyte Membrane
November 10, 2022
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...
November 10, 2022
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...
November 7, 2022
Results from ORION-3 open-label trial show twice-yearly* Leqvio(inclisiran), as a complement to statin therapy, provides effective and sustained reductions in low-density lipoprotein cholesterol (LDL-C)